imiquimod has been researched along with Metastase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agorio, CI; Bascuas, T; Chabalgoity, JA; Mónaco, A; Moreno, M; Rimsky, G; Vola, M | 1 |
| Caruntu, C; Constantin, MM; Draghici, CC; Lisievici, CV; Lupu, M; Popa, AV; Sebe, TI; Solomon, I; Vajaitu, C; Voiculescu, VM | 1 |
| Chen, L; Chen, Y; Guo, L; Liu, C; Ren, W; Sun, L; Xu, H; Yin, H; Yu, L; Yue, W; Zhang, K; Zhang, Y; Zhou, B | 1 |
| Adams, S; Bedognetti, D; Chiriboga, L; Darvishian, F; Demaria, S; Egeblad, M; Heguy, A; Hendrickx, W; Loomis, C; Marincola, FM; Ray, K; Rozenblit, M | 1 |
| Burrall, BA; Christensen, SD; Fitzmaurice, SD; Fung, MA; Garcia, MS; Joo, J; King, B; Konia, T; Leventhal, J; Martinez, S; Maverakis, E; Monjazeb, AM; Patel, F; Shi, VY; Tran, K; Wilken, R | 1 |
| Baradad, M; Martí, R; Nagore, E; Ortiz-Brugués, A; Requena, C; Rivas-Tolosa, N; Sanmartín, V; Soriano, V; Toledo-Pastrana, T; Traves, V | 1 |
| Desmedt, E; Florin, V; Mortier, L; Vercambre-Darras, S | 1 |
| Beiteke, U; Grabbe, S; Loquai, C; Luger, TA; Metze, D; Nashan, D; Rüping, KW | 1 |
| Fenske, NA; Glass, LF; Prakash, AV; Shistik, G | 1 |
| Altschuler, EL; Kast, RE | 1 |
1 review(s) available for imiquimod and Metastase
| Article | Year |
|---|---|
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cytokines; Diterpenes; Fluorouracil; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Metastasis; Skin; Skin Neoplasms; Toll-Like Receptor 7 | 2019 |
2 trial(s) available for imiquimod and Metastase
| Article | Year |
|---|---|
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.
Topics: Adult; Aged; Breast Neoplasms; CD8-Positive T-Lymphocytes; Female; Gene Expression Profiling; Humans; Imiquimod; Immunity, Cellular; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Th1 Cells | 2019 |
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Skin Ulcer; Treatment Outcome | 2012 |
7 other study(ies) available for imiquimod and Metastase
| Article | Year |
|---|---|
TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Female; Imiquimod; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microbial Viability; Neoplasm Metastasis; Salmonella typhi; Survival Analysis; Toll-Like Receptor 7; Treatment Outcome; Tumor Burden; Tumor Microenvironment | 2018 |
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Immunological; Apoptosis; B7-H1 Antigen; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Hematoporphyrins; Humans; Imiquimod; Immunotherapy; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasms; Treatment Outcome; Ultrasonic Therapy | 2019 |
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Topics: Administration, Topical; Aminoquinolines; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Retinoids; Retrospective Studies; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2015 |
Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryosurgery; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms | 2016 |
[Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon Inducers; Interferon-alpha; Interleukin-2; Melanoma; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Time Factors | 2004 |
Treatment of locally metastatic melanoma: a novel approach.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Skin Neoplasms; Treatment Outcome | 2007 |
Intraperitoneal lavage with imiquimod to eliminate epithelial ovarian cancer micro metastases.
Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials as Topic; Female; Humans; Imiquimod; Infusions, Parenteral; Models, Immunological; Neoplasm Metastasis; Ovarian Neoplasms | 2008 |